Neurosense Therapeutics Ltd (NRSN)

US · Healthcare · Biotechnology

$6.72+3.54%

Last close · 2026-09-17

Key statistics

Market cap

$12.3M

Forward P/E

0.0

P/B

2.64

Book value

$-0.96

EPS (TTM)

$-8.80

52-week high

$7.50

52-week low

$0.25

50-day MA

$10.19

200-day MA

$15.30

Beta

1.58

Analysts rate Neurosense Therapeutics Ltd a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $6.50.

Insiders

25.65%

Institutions

0.89%

Fund	Stake
Yorkville Advisors Global, LP	0.21%
Independent Advisor Alliance	0.13%
UBS Group AG	0.13%
Two Sigma Investments LLC	0.12%
Meitav Dash Investments Ltd	0.11%
Jane Street Group LLC	0.08%
Commonwealth Equity Services, LLC	0.06%
PNC Financial Services Group Inc	0.06%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Neurosense Therapeutics Ltd — free to start.

Data updated 2026-09-18.